Experimental drug attacks cancer by forcing sugar consumption while blocking fat metabolism
Reported bySciTechDaily ↗·Sourced by Goodlede
University of Texas researchers developed a compound (XJ-4-85) that simultaneously accelerates sugar metabolism in cancer cells while blocking fat metabolism, killing most melanoma cells in mice while sparing healthy cells. The compound also showed activity against human melanoma, leukemia, breast, lung, liver, and neuroblastoma cells in laboratory experiments.
The findings are from mouse models and human cell culture; clinical translation in humans will require further research and testing.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at SciTechDaily
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede